Escalon Medical Corp. (ESMC) Fair Value 2026

ESMC · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.7 /10

32 fundamental signals · 8 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-08-27, Escalon Medical Corp. (ESMC) trades at $0.17, versus a $0.62 median fair value across its 8 active models — 266.3% above the current price. QOC: 8.7/10. Value Trap Risk: 24/100 (SAFE). 8/13 models active. Within that set, the Bayesian DCF component alone returns $0.37.

Key Facts

Ticker
ESMC
Price
$0.17
Quality Score
8.7/10
Value Trap Risk
24/100
Models Active
8/13
Last Updated
Strength: Dynamic NAV suggests +321.2% upside with 57% confidence
Risk: Limited model coverage (8/13) may reduce confidence

Is Escalon Medical Corp. (ESMC) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, Escalon Medical Corp. (ESMC) appears undervalued as of : the median of 8 independent fair value estimates is $0.62, 266.3% above the current price of $0.17. Estimates range from $0.15 to $0.92. ESMC scores 8.7/10 on fundamental quality and 24/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. ESMC’s +266.3% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Escalon Medical Corp. Stock in 2026? →

What Fair Value Does Each Model Give ESMC?

8 Intrinsic Value Models vs. Current Price ($0.17)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.37 +118.7%
Ensemble · Low Conviction
 $0.69 +305.9%
Asset-Based · High Conviction
 $0.72 +321.2%
Intrinsic · High Conviction
 $0.50 +192.2%
Unlock the Full Matrix

Access 4 additional models including EROIC Spread, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is ESMC's Fair Value Range?

Spread across 8 independent models · $0.15 to $0.92

CirclFi's 8 active models place Escalon Medical Corp. (ESMC) between $0.15 and $0.92 per share, a spread of 123% of the median. The median of that range — $0.62 — is the fair value CirclFi publishes for ESMC, against a current price of $0.17.

Low · Regime CrossHigh · EROIC
$0.15median $0.62$0.92
Where the range comes from
Most bearish modelRegime Cross-Sectional$0.15
Most bullish modelEROIC Spread$0.92
Model agreement7 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for ESMC. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on ESMC, not a CirclFi price target. How each model works →

What Is Escalon Medical Corp. (ESMC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Escalon Medical Corp. is potentially undervalued at its current price of $0.17. Based on our 13-model framework, Escalon Medical Corp.'s intrinsic value is estimated at a median fair value of $0.62 — representing +266.3% implied upside — with 7 out of 8 active models confirming this thesis. Model dispersion is worth noting: EROIC targets $0.92 (+441.8%), versus Regime Cross at $0.15 (-9.0%). This +450.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About ESMC?

8 of 13 models are currently active for ESMC. Of these, 7 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for ESMC is $0.62 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $0.37 on its own, implying +118.7% upside from the current price. See which stocks rank higher →

How Does ESMC Rank in Medical Devices?

Among 157 Medical Devices stocks, ESMC ranks #14 by Quality of Company score. CirclFi's QOC score of 8.7/10 evaluates 32 fundamental signals. A score of 8.7 places ESMC in the top tier.

See all Most Undervalued Medical Devices Stocks →

Escalon Medical Corp.'s positioning within the Medical Devices segment means that FDA approval probability plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.

Is ESMC a Value Trap?

CirclFi's Value Trap algorithm assigns ESMC a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Escalon Medical Corp.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Escalon Medical Corp. earns a quality score of 8.7/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +450.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ESMC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ESMC's 8 active models, average confidence is 47%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Escalon Medical Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

TCMDTactile Systems Technology, Inc.QOC 8.8EWEdwards Lifesciences CorporationQOC 8.7ABTAbbott LaboratoriesQOC 8.8SNNSmith & Nephew plcQOC 8.7PENPenumbra, Inc.QOC 8.9INMDInMode Ltd.QOC 8.5CTKBCytek Biosciences, Inc.QOC 6.9BTCYBiotricity, Inc.QOC 6.0RMSLREMSleep Holdings, Inc.QOC 4.6IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: TCMD · EW · ABT · SNN · PEN · INMD · CTKB · BTCY · RMSL · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to ESMC?

7 companies across all industries closest to ESMC’s Quality of Company score of 8.7/10.

DDOGDatadog, Inc.QOC 8.7TCBKTriCo BancsharesQOC 8.7SELFGlobal Self Storage, Inc.QOC 8.7TELTE Connectivity plcQOC 8.7AMDAdvanced Micro Devices, Inc.QOC 8.7MNSTMonster Beverage CorporationQOC 8.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: DDOG · TCBK · SELF · TEL · AMD · MNST · NVDA

Where Does ESMC Sit in CirclFi's Medical Devices Rankings?

ESMC is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Escalon Medical Corp.’s Valuation?

What is Escalon Medical Corp.'s intrinsic value in 2026?

CirclFi puts Escalon Medical Corp. (ESMC)'s intrinsic value at $0.62 — the median of 8 independent model estimates as of 2026-08-27, ranging from $0.15 to $0.92. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $0.37 on its own. The Quality of Company score is 8.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ESMC overvalued or undervalued right now?

At $0.17, 7 of 8 active models suggest ESMC may be undervalued, while 1 indicate potential overvaluation. The median of all 8 fair value estimates is $0.62, 266.3% above the current price of $0.17 — a consensus view that ESMC is undervalued. The assessment depends on which methodology best fits Escalon Medical Corp.'s business model in Medical Devices.

What does a Quality of Company score of 8.7 mean for ESMC?

Escalon Medical Corp.'s QOC of 8.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on ESMC?

CirclFi analyzes ESMC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on ESMC?

Of the 8 models currently active on ESMC, EROIC Spread is the most bullish at $0.92 per share, and Regime Cross-Sectional is the most bearish at $0.15. CirclFi's published fair value for ESMC is the median of that range, $0.62, not either extreme. The gap between the two ends equals 123% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is ESMC a value trap in 2026?

Escalon Medical Corp.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 8-model valuation engine, Escalon Medical Corp. (ESMC) has a median fair value of $0.62 — 266.3% above the current price of $0.17 — as of 2026-08-27.” Source: circlfi.com/stock/ESMC/ · Methodology
Primary sources for this ESMC valuation
  • Financial statements: Escalon Medical Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0000862668) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ESMC as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on ESMC.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for ESMC Unlock All 8 — $39/mo